Sort
21,453 grants matching “tuberculosis”
Sustainable One Health Research Training Capacity: Molecular Epidemiology of Zoonotic Foodborne and Waterborne Pathogens in Eastern Africa
$256,816Wondwossen A. Gebreyes · Ohio State University · D43 · FY2021 · TW
Sustainable One Health Research Training Capacity: Molecular Epidemiology of Zoonotic Foodborne and Waterborne Pathogens in Eastern Africa
$256,793Wondwossen A. Gebreyes · Ohio State University · D43 · FY2020 · TW
Feedback regulation and transcirptional coupling in bacterial stress-response
$256,714Oleg Igoshin · Rice University · R01 · FY2014 · GM
Functions and mechanisms of M. tuberculosis S/T kinases
$256,692University Of California Berkeley · R01 · FY2005 · GM
The University of Texas Medical Branch Summer Institute in Biostatistics and Data Science (UTMB-SIBDS)
$256,671Heidi Spratt · University Of Texas Med Br Galveston · R25 · FY2023 · HL
MONOCYTE RECRUITMENT IN PLEUROPULMONARY TB IN AIDS
$256,614University Of Florida · R01 · FY2004 · AI
A Phase 2C Randomized, Controlled, Open-Label Trial of Novel Shortened Regimens for the Treatment of Isoniazid-Monoresistant TB (IMR-TB)
$256,504Gustavo Eduardo Velasquez · University Of California, San Francisco · R34 · FY2024 · AI
The HLA-E peptidome in HIV infection
$256,500Sylvie Le Gall · Massachusetts General Hospital · R21 · FY2017 · AI
Sustainable One Health Research Training Capacity: Molecular Epidemiology of Zoonotic Foodborne and Waterborne Pathogens in Eastern Africa
$256,489Wondwossen A. Gebreyes · Ohio State University · D43 · FY2018 · TW
The impact of mucociliary clearance on Mycobacterium tuberculosis pathogenesis
$256,475Javeed Ali Shah · University Of Washington · R21 · FY2023 · AI
Addressing Psychosocial Needs and HIV Risk in Indian MSM
$256,466Steven A Safren · Massachusetts General Hospital · R21 · FY2009 · MH
Wits HIV Research Group CLINICAL TRIAL UNIT (CTU) Administrative supplement - COP18
$256,406Ian Matthias Sanne · Wits Health Consortium (Pty), Ltd · UM1 · FY2024 · AI
Marine Fatty Acids as New Antifungal, Antimycobacterial, and Topo-l Agents
$256,375Nestor Manuel Carballeira · University Of Puerto Rico Rio Piedras · SC1 · FY2009 · GM
Marine Fatty Acids as New Antifungal, Antimycobacterial, and Topo-l Agents
$256,375Nestor Manuel Carballeira · University Of Puerto Rico Rio Piedras · SC1 · FY2010 · GM
Development of synergistic clofazimine-amikacin inhalable powders for the treatment of pulmonary Mycobacterium abscessus infections
$256,350Zachary N Warnken · Via Therapeutics, Llc · R43 · FY2021 · AI
Role of Macrophage Arginase in Anti-Bacterial Immunity
$256,332Peter J. Murray · St. Jude Children'S Research Hospital · R01 · FY2006 · AI
Human and Tuberculin CoA Biosynthetic Enzyme Structures
$256,332Tina Izard · St. Jude Children'S Research Hospital · R01 · FY2006 · AI
Stigma and Tuberculosis in Haitian Populations
$256,250University Of South Florida · R01 · FY2004 · TW
Role of Iron-Oxo Clusters in Fatty Acid Desaturation
$256,210Brian G. Fox · University Of Wisconsin-Madison · R01 · FY2007 · GM
Tuberculosis Control
$256,173Kathleen Ritger · Chicago Department Of Public Health · U52 · FY2016 · PS
Technology Core: Proteomics
$256,103Steven A. Carr · Harvard School Of Public Health · U19 · FY2013 · AI
HAITI AIDS RESEARCH TRAINING: MODELS TO IMPLEMENTATION
$256,020Weill Medical College Of Cornell Univ · U2R · FY2004 · TW
STTR Phase I: Recombinant BCG as a novel immunoadjuvant for viral infections
$256,000Todd Wallach · Oncosting Llc · · FY2022 · TIP
Regulation of host response genes in pathogenesis of TB
$256,000Emory University · R01 · FY2001 · HL
Adaptive evaluation of mHealth and conventional adherence support interventions to optimize outcomes with new treatment regimens for drug-resistant tuberculosis and HIV in South Africa
$256,000Max O'Donnell · Columbia University Health Sciences · R01 · FY2025 · AI